Results 21 to 30 of about 518,020 (377)
A 55-year-old woman who had received an implantable left ventricular assist device 3 months earlier presented with dyspnea and a low-flow alarm of the device.
Yoonseo Lee+5 more
doaj +1 more source
Mechanical Circulatory Assist Devices: Which Is the Best Device as Bridge to Heart Transplantation? [PDF]
Introduction: Heart transplantation is the recommended treatment method for patients with advanced heart failure that is refractory to clinical treatment.
Adriana Natucci Hette+1 more
doaj +1 more source
Background: Left ventricular assist device (LVAD) unloading and hemodynamic support in patients with advanced chronic heart failure can result in significant improvement in cardiac function allowin...
E. Birks+16 more
semanticscholar +1 more source
Clinical implications of pleural effusion following left ventricular assist device implantation [PDF]
Background Studies on the association between pleural effusion (PE) and left ventricular assist devices (LVADs) are limited. This study aimed to examine the characteristics and the clinical impact of PE following LVAD implantation.
So-Min Lim+6 more
doaj +1 more source
Reverse Remodeling With Left Ventricular Assist Devices.
This review provides a comprehensive overview of the past 25+ years of research into the development of left ventricular assist device (LVAD) to improve clinical outcomes in patients with severe end-stage heart failure and basic insights gained into the ...
D. Burkhoff+3 more
semanticscholar +1 more source
Asistencias circulatorias pulsátiles [PDF]
ResuménLa incidencia de insuficiencia cardíaca aumenta de año en año; en las fases más avanzadas de la enfermedad, el tratamiento farmacológico, los dispositivos de resincronización y la cirugía convencional llegan a ser ineficaces.
Aurelio Sarralde, José+1 more
core +2 more sources
Background: Malignancy is a significant, life-limiting complication after lung transplantation (LuTx) and the second common long-term cause of death. We aimed to investigate its incidence and effect on the outcome.
Konstantina Spetsotaki+5 more
doaj
Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
This paper describes a case of early (7 months after transplant) cardiac allograft vasculopathy. This-43-year-old (CMV positive, EBV negative) female patient underwent an orthotopic heart transplant with a (CMV negative, EBV positive) donor heart.
Ashim Aggarwal+3 more
doaj +1 more source
Biventricular assist devices and total artificial heart: Strategies and outcomes
In contrast to the advanced development of the left ventricular assist device (LVAD) therapy for advanced heart failure, the mechanical circulatory support (MCS) with biventricular assist device (BVAD) and total artificial heart (TAH) options remain ...
Taiyo Kuroda+5 more
doaj +1 more source
Importance Left ventricular assist devices (LVADs) improve outcomes in patients with advanced heart failure, but little is known about the role of neurohormonal blockade (NHB) in treating these patients. Objective To analyze the association between NHB
M. McCullough+12 more
semanticscholar +1 more source